Hepatopulmonary syndrome other diagnostic studies: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
OR | OR | ||
'''Pulmonary function tests''' may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) suggesting a diffusion impairment as afrequent finding in hepatopulmonary syndrome (occurring in up to 80% of patients). '''Six minute walk test with and without an oxygen titration''' can also use as an objective assessment of exercise capacity. | |||
Other diagnostic studies for hepatopulmonary syndrome include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3]. | Other diagnostic studies for hepatopulmonary syndrome include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3]. | ||
| Line 15: | Line 13: | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include: | '''Pulmonary Function Tests''' | ||
* Usually PFT in HPS patients usually reveal normal flows and lung volumes, | |||
* Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome. | |||
* Findings suggestive of hepatopulmonary syndrome include: | |||
*Diffusion impairment is a frequent finding in HPS, occurring in up to 80% of patients. | |||
*''Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well,'' ''(50-70% of cirrhotic patients)'' | |||
*A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding. | |||
*A mean DLCO of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS . | |||
*Reduced lung volumes might barely observed in tense ascites or in the presence of pleural effusions due to oncotic disturbance or other reasons. (neither specific nor sensitive) | |||
'''Six Minute Walk Test With and Without an Oxygen Titration''' | |||
* Objective assessment of exercise capacity | |||
* A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements. | |||
==References== | ==References== | ||
Revision as of 22:40, 29 July 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome other diagnostic studies |
|
Hepatopulmonary syndrome other diagnostic studies in the news |
|
Risk calculators and risk factors for Hepatopulmonary syndrome other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
There are no other diagnostic studies associated with hepatopulmonary syndrome.
OR
Pulmonary function tests may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) suggesting a diffusion impairment as afrequent finding in hepatopulmonary syndrome (occurring in up to 80% of patients). Six minute walk test with and without an oxygen titration can also use as an objective assessment of exercise capacity.
Other diagnostic studies for hepatopulmonary syndrome include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
Pulmonary Function Tests
- Usually PFT in HPS patients usually reveal normal flows and lung volumes,
- Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome.
- Findings suggestive of hepatopulmonary syndrome include:
- Diffusion impairment is a frequent finding in HPS, occurring in up to 80% of patients.
- Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well, (50-70% of cirrhotic patients)
- A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding.
- A mean DLCO of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS .
- Reduced lung volumes might barely observed in tense ascites or in the presence of pleural effusions due to oncotic disturbance or other reasons. (neither specific nor sensitive)
Six Minute Walk Test With and Without an Oxygen Titration
- Objective assessment of exercise capacity
- A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements.